Sustainable manufacturing is one of the most common demands industries, such as the pharmaceutical, chemical, and biotechnological industries, are faced with today...
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
25.01.2018
- US healthcare giant Johnson & Johnson has just been handed its second defeat in patent litigation this month. On Jan. 23, a US appeals court hearing J&J’s challenge to a lower...
14.07.2017
- The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...
07.03.2017
- In the final instance, DSM Dyneema has won a protracted patent challenge against publicly held FMS Enterprises Migun of Tel Aviv. The firm had attempted to block the Dutch...
08.02.2017
- Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...
24.01.2017
- US drugmaker Merck has settled its patent dispute with rival Bristol-Myers Squibb (BMS) and Japan’s Ono Pharmaceutical over cancer immunotherapy Keytruda. Under terms of the...
